Fukuhara, T.; Imai, K.; Nakagawa, T.; Igusa, R.; Yokota, H.; Watanabe, K.; Suzuki, A.; Morita, M.; Onodera, R.; Inoue, A.;
et al. A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety. Biomedicines 2023, 11, 2501.
https://doi.org/10.3390/biomedicines11092501
AMA Style
Fukuhara T, Imai K, Nakagawa T, Igusa R, Yokota H, Watanabe K, Suzuki A, Morita M, Onodera R, Inoue A,
et al. A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety. Biomedicines. 2023; 11(9):2501.
https://doi.org/10.3390/biomedicines11092501
Chicago/Turabian Style
Fukuhara, Tatsuro, Kazuhiro Imai, Taku Nakagawa, Ryotaro Igusa, Hayato Yokota, Kana Watanabe, Aya Suzuki, Mami Morita, Ren Onodera, Akira Inoue,
and et al. 2023. "A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety" Biomedicines 11, no. 9: 2501.
https://doi.org/10.3390/biomedicines11092501
APA Style
Fukuhara, T., Imai, K., Nakagawa, T., Igusa, R., Yokota, H., Watanabe, K., Suzuki, A., Morita, M., Onodera, R., Inoue, A., Miura, M., Minamiya, Y., & Maemondo, M.
(2023). A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety. Biomedicines, 11(9), 2501.
https://doi.org/10.3390/biomedicines11092501